Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

The global precision diagnostics and medicine market, valued at US$132.46 billion in 2023, is forecasted to grow at a robust CAGR of ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.

Many of the most devastating infectious diseases are caused by RNA viruses, and Model Medicines is working on one compound to ...

We recently compiled a list of the 10 Trending AI Stocks on Latest News and Ratings. In this article, we are going to take a ...

UCB, a global biopharmaceutical company, announced today that a single-injection 2 mL prefilled syringe and autoinjector, each containing 320 mg of ...

Dual blocking SHP2 and FGFR2 can not only promote the targeted tumor-killing effects and overcome FGFR2 inhibitor resistance caused by feedback activation, but also activate T cell-mediated anti-tumor ...

Transforming the landscape of drug discovery with next-gen capabilities in obesity research, small molecule and antibody design, antibody-drug conjugate development, and interactive AI AlpaMeld Logo ...

Scientific Computing World is hosting a virtual roundtable (limited to 6-8 participants) in February (date tbc) for research leaders, scientists and R&D experts in drug discovery, particularly those ...

The stake comes alongside an agreement for Vancouver, Washington-based Absci to use AMD chips and software to power its drug ...

CEO and founder Erez Kaminski also shared his vision for 2025, including some bold predictions about AI for the coming year ... company dedicated to democratizing access to cutting edge drug discovery ...